Ultragenyx Historical Financial Ratios
| RARE Stock | USD 46.02 0.38 0.82% |
Ultragenyx is promptly reporting on over 107 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 6.94, Invested Capital of 0.0, Average Payables of 0.0 or Stock Based Compensation To Revenue of 0.3 will help investors to properly organize and evaluate Ultragenyx financial condition quickly.
Ultragenyx |
About Ultragenyx Financial Ratios Analysis
UltragenyxFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Ultragenyx investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Ultragenyx financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Ultragenyx history.
Ultragenyx Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Ultragenyx stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Ultragenyx sales, a figure that is much harder to manipulate than other Ultragenyx multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Ultragenyx dividend as a percentage of Ultragenyx stock price. Ultragenyx dividend yield is a measure of Ultragenyx stock productivity, which can be interpreted as interest rate earned on an Ultragenyx investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Most ratios from Ultragenyx's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Ultragenyx current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ultragenyx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.At present, Ultragenyx's Book Value Per Share is projected to increase based on the last few years of reporting. The current year's PB Ratio is expected to grow to 16.58, whereas Days Sales Outstanding is forecasted to decline to 58.60.
| 2023 | 2024 (projected) | Dividend Yield | 0.0031 | 0.002755 | Price To Sales Ratio | 8.1 | 7.69 |
Ultragenyx fundamentals Correlations
Click cells to compare fundamentals
Ultragenyx Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ultragenyx fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 23.3 | 31.08 | 16.22 | 8.92 | 8.1 | 7.69 | |
| Ptb Ratio | 3.7 | 7.3 | 6.18 | 9.19 | 12.77 | 16.58 | |
| Days Sales Outstanding | 115.59 | 31.1 | 29.53 | 40.63 | 61.69 | 58.6 | |
| Book Value Per Share | 11.56 | 18.97 | 13.61 | 5.04 | 3.74 | 6.94 | |
| Free Cash Flow Yield | (0.13) | (0.14) | (0.15) | (0.0209) | (0.0722) | (0.16) | |
| Operating Cash Flow Per Share | (6.1) | (2.17) | (5.0) | (5.44) | (6.46) | (6.78) | |
| Stock Based Compensation To Revenue | 1.56 | 0.79 | 0.32 | 0.3 | 0.36 | 0.31 | |
| Pb Ratio | 3.7 | 7.3 | 6.18 | 9.19 | 12.77 | 16.58 | |
| Ev To Sales | 19.47 | 28.62 | 15.47 | 8.64 | 7.71 | 7.32 | |
| Free Cash Flow Per Share | (6.54) | (2.89) | (6.07) | (7.53) | (7.09) | (7.45) | |
| Roic | (0.61) | (0.65) | (0.29) | (1.8) | (2.06) | (1.96) | |
| Inventory Turnover | 0.78 | 0.47 | 0.99 | 1.06 | 1.33 | 1.4 | |
| Days Of Inventory On Hand | 467.84 | 777.05 | 370.08 | 344.97 | 274.25 | 260.54 | |
| Research And Ddevelopement To Revenue | 3.45 | 1.52 | 1.41 | 1.94 | 1.49 | 1.42 | |
| Capex To Revenue | 0.24 | 0.16 | 0.21 | 0.4 | 0.11 | 0.1 | |
| Cash Per Share | 13.35 | 19.75 | 10.92 | 10.7 | 7.85 | 6.86 | |
| Pocfratio | (7.0) | (63.7) | (16.83) | (8.51) | (7.41) | (7.78) | |
| Capex To Operating Cash Flow | (0.0719) | (0.33) | (0.22) | (0.38) | (0.0985) | (0.1) | |
| Pfcf Ratio | (6.53) | (47.82) | (13.84) | (6.15) | (6.74) | (7.08) | |
| Days Payables Outstanding | 521.53 | 769.6 | 390.77 | 557.73 | 340.01 | 323.01 | |
| Income Quality | 0.84 | 1.47 | 0.86 | 0.71 | 0.54 | 0.78 | |
| Roe | (0.62) | (0.16) | (0.49) | (2.01) | (2.2) | (2.09) | |
| Ev To Operating Cash Flow | (5.85) | (58.67) | (16.05) | (8.25) | (7.05) | (7.4) | |
| Pe Ratio | (6.0) | (45.15) | (12.56) | (4.58) | (5.8) | (6.09) | |
| Return On Tangible Assets | (0.42) | (0.12) | (0.34) | (0.53) | (0.47) | (0.5) | |
| Ev To Free Cash Flow | (5.46) | (44.05) | (13.2) | (5.96) | (6.42) | (6.74) | |
| Earnings Yield | (0.0913) | (0.17) | (0.0221) | (0.0796) | (0.22) | (0.18) | |
| Intangibles To Total Assets | 0.15 | 0.0998 | 0.12 | 0.13 | 0.14 | 0.2 | |
| Net Debt To E B I T D A | 1.02 | 4.76 | 0.65 | 0.16 | 0.33 | 0.31 | |
| Current Ratio | 8.24 | 6.83 | 4.72 | 3.38 | 2.61 | 2.48 | |
| Tangible Book Value Per Share | 8.49 | 16.09 | 11.02 | 2.12 | 0.88 | 0.84 | |
| Receivables Turnover | 3.16 | 11.74 | 12.36 | 8.98 | 5.92 | 5.34 | |
| Graham Number | 43.02 | 36.18 | 45.28 | 33.88 | 26.36 | 22.54 | |
| Shareholders Equity Per Share | 11.56 | 18.97 | 13.61 | 5.04 | 3.74 | 6.94 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ultragenyx is a strong investment it is important to analyze Ultragenyx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ultragenyx's future performance. For an informed investment choice regarding Ultragenyx Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ultragenyx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ultragenyx. If investors know Ultragenyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ultragenyx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.35) | Revenue Per Share 6.015 | Quarterly Revenue Growth 0.423 | Return On Assets (0.24) | Return On Equity (2.90) |
The market value of Ultragenyx is measured differently than its book value, which is the value of Ultragenyx that is recorded on the company's balance sheet. Investors also form their own opinion of Ultragenyx's value that differs from its market value or its book value, called intrinsic value, which is Ultragenyx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ultragenyx's market value can be influenced by many factors that don't directly affect Ultragenyx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ultragenyx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultragenyx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultragenyx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.